Product Information
Product TypeRabbit Polyclonal IgG, primary antibodies
Positive controlHepG2
Project IDR080410
Molecular Weight~43kDa
PurityAffinity purified
Recommended DilutionsWB: 1:500-1:1,000 ICC: 1:100
Cellular localizationCell Membrane
Form Or Antibody
Form of Antibody1*TBS (pH7.4), 0.5%BSA, 25%Glycerol. Preservative: 0.05% Sodium Azide.
BackgroundCD9 antigen is a glycoprotein expressed on the surface of developing B lymphocytes, platelets, monocytes, eosinophils, basophil, stimulated T lymphocytes and by neurons and glial cells in the peripheral nervous system. Protein exists in three forms, and is known to carry covalently linked fatty acids. It is involved in platelet activation, aggregation, in cell adhesion, cell motility and tumor metastasis. It regulates paranodal junction formation, and is also required for gamete fusion.
Storage/StabilityStore at +4°C after thawing. Aliquot store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
Specificty Sensitivity
Specificity/SensitivityThis antibody is produced by immunizing rabbits with a synthetic peptide (KLH-coupled) corresponding to a region of N-terminal residues of CD9.
References1 Higashihara M., Takahata K., Yatomi Y., Nakahara K., Kurokawa K.; "Purification and partial characterization of CD9 antigen of human platelets."; FEBS Lett. 264:270-274(1990).
2 Ikeyama S., Koyama M., Yamaoko M., Sasada R., Miyake M.; "Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA."; J. Exp. Med. 177:1231-1237(1993).
3 Rubinstein E., Benoit P., Billard M., Plaisance S., Prenant M., Uzan G., Boucheix C.; "Organization of the human CD9 gene."; Genomics 16:132-138(1993).